[HTML][HTML] SARS-CoV-2 seroprevalence among healthcare, first response, and public safety personnel, Detroit metropolitan area, Michigan, USA, May–June 2020

LJ Akinbami, N Vuong, LR Petersen… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
To estimate seroprevalence of severe acute respiratory syndrome 2 (SARS-CoV-2) among
healthcare, first response, and public safety personnel, antibody testing was conducted in …

[HTML][HTML] Prevalence of SARS-CoV-2 antibodies in first responders and public safety personnel, New York City, New York, USA, May–July 2020

S Sami, LJ Akinbami, LR Petersen… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
We conducted a serologic survey in public service agencies in New York City, New York,
USA, during May–July 2020 to determine prevalence of severe acute respiratory syndrome …

Seroprevalence of severe acute respiratory syndrome coronavirus 2 following the largest initial epidemic wave in the United States: findings from New York City, 13 …

P Pathela, A Crawley, D Weiss, B Maldin… - The Journal of …, 2021 - academic.oup.com
Abstract Background New York City (NYC) was the US epicenter of the spring 2020
coronavirus disease 2019 (COVID-19) pandemic. We present the seroprevalence of severe …

Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020

P Pathela, A Crawley, D Weiss, B Maldin… - The Journal of …, 2021 - stacks.cdc.gov
Abstract Background New York City (NYC) was the US epicenter of the Spring 2020 COVID-
19 pandemic. We present seroprevalence of SARS-CoV-2 infection and correlates of …

[HTML][HTML] Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network—13 academic medical centers, April–June 2020

WH Self - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Among 3,248 personnel observed, 6% had antibody evidence of previous SARS-CoV-2
infection; 29% of personnel with SARS-CoV-2 antibodies were asymptomatic in the …

[HTML][HTML] Seroprevalence of SARS-CoV-2 and infection fatality ratio, Orleans and Jefferson parishes, Louisiana, USA, May 2020

AK Feehan, D Fort, J Garcia-Diaz… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Using a novel recruitment method and paired molecular and antibody testing for severe
acute respiratory syndrome coronavirus 2 infection, we determined seroprevalence in a …

Serologic status and SARS-CoV-2 infection over 6 months of follow up in healthcare workers in Chicago: a cohort study

JT Wilkins, LR Hirschhorn, EL Gray, A Wallia… - Infection Control & …, 2022 - cambridge.org
Objective: To determine the changes in severe acute respiratory coronavirus virus 2 (SARS-
CoV-2) serologic status and SARS-CoV-2 infection rates in healthcare workers (HCWs) over …

Prevalence of SARS-CoV-2 antibodies in New York City adults, June–October 2020: a population-based survey

JC Parrott, AN Maleki, VE Vassor… - The Journal of …, 2021 - academic.oup.com
Background Serosurveys help to ascertain burden of infection. Prior severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) serosurveys in New York City (NYC) used …

Rapid emergence of SARS-CoV-2 in the greater New York metropolitan area: geolocation, demographics, positivity rates, and hospitalization for 46 793 persons …

SB Reichberg, PP Mitra, A Haghamad… - Clinical Infectious …, 2020 - academic.oup.com
Abstract Background In March 2020, the greater New York metropolitan area became an
epicenter for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The …

Risk factors for testing positive for severe acute respiratory syndrome coronavirus 2 in a national United States healthcare system

VS Fan, JA Dominitz, MKC Eastment… - Clinical Infectious …, 2021 - academic.oup.com
Background Identifying risk factors for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection could help health systems improve testing and screening strategies …